FDA data Registry peer set 1 peer

Alternatives to leuprolide

1 same-class SPL records vs leuprolide - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View leuprolide → All alternatives

Brand: Lupron

GnRH Agonist Prescription 1 alternative found

About leuprolide

VABRINTY is a medicine that treats advanced prostate cancer. It contains leuprolide, which lowers testosterone levels.

Used for: VABRINTY treats advanced prostate cancer in men. Prostate cancer is when cells in the prostate gland grow out of control. This medicine helps to slow down the growth of the cancer.

View full leuprolide profile →

1 GnRH Agonist peers (wide set)

goserelin

Rx

Zoladex

Zoladex, along with flutamide, can treat prostate cancer that has not spread far. It can also help with advanced prostate cancer to ease symptoms. For women, Zoladex can treat endometriosis to reduce pain and lesions. It can also thin the lining of the uterus before a procedure for abnormal bleeding. Zoladex can also treat advanced breast cancer in women who have not gone through menopause.

Compare leuprolide vs goserelin side-by-side →

leuprolide vs goserelin · FAERS reaction fields

FAERS top-reaction field "Malignant Neoplasm Progression" shows the widest count spread between leuprolide and goserelin in this extract (1,231-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect leuprolide goserelin
Fatigue 82 837
Nausea 61 556
Headache 58 385
Malignant Neoplasm Progression 53 1,284
Disease Progression 50 313
Febrile Neutropenia 43 -
Product Storage Error 41 -
Hot Flush 36 511

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

leuprolide peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for GnRH Agonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside leuprolide? ▼
This registry lists 1 GnRH Agonist medication records beside leuprolide, including goserelin. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide GnRH Agonist peer set (1 records)

leuprolide (Lupron) sits in a wide GnRH Agonist peer set (1 of 1 class peers shown). Labeled indication field for leuprolide: VABRINTY treats advanced prostate cancer in men.

Top FAERS reaction fields for leuprolide total 494 reports across 10 reactions, set beside goserelin. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full leuprolide profile →

Field note for leuprolide: see also the generic vs brand label guide when reading Lupron SPL strings.

Read our methodology - how this data is sourced, computed, and verified.